Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $137.9 million.

  • Avidity Biosciences' Shares Outstanding (Weighted Average) rose 1176.9% to $137.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.9 million, marking a year-over-year increase of 1176.9%. This contributed to the annual value of $111.6 million for FY2024, which is 5282.69% up from last year.
  • According to the latest figures from Q3 2025, Avidity Biosciences' Shares Outstanding (Weighted Average) is $137.9 million, which was up 1176.9% from $129.6 million recorded in Q2 2025.
  • Avidity Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $137.9 million for Q3 2025, and its period low was $37.5 million during Q1 2021.
  • For the 5-year period, Avidity Biosciences' Shares Outstanding (Weighted Average) averaged around $77.8 million, with its median value being $71.4 million (2023).
  • As far as peak fluctuations go, Avidity Biosciences' Shares Outstanding (Weighted Average) surged by 121884.01% in 2021, and later soared by 1176.9% in 2025.
  • Avidity Biosciences' Shares Outstanding (Weighted Average) (Quarter) stood at $41.4 million in 2021, then grew by 25.91% to $52.2 million in 2022, then surged by 39.97% to $73.0 million in 2023, then skyrocketed by 52.83% to $111.6 million in 2024, then increased by 23.58% to $137.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $137.9 million for Q3 2025, versus $129.6 million for Q2 2025 and $129.2 million for Q1 2025.